Literature DB >> 19815275

Murine BAFF-receptor residues 168-175 are essential for optimal CD21/35 expression but dispensable for B cell survival.

Christopher G Mayne1, Ian J Amanna, Colleen E Hayes.   

Abstract

BAFF-R (B cell-activating factor belonging to the tumor necrosis factor family receptor) regulates B lymphocyte survival, maturation, homeostasis, and self-tolerance through signaling mechanisms that are not completely understood. A spontaneous BAFF-R mutation, Bcmd-1, disrupts BAFF-R signaling. However, it is not clear why the Bcmd-1-encoded BAFF-R fails to adequately support B cell survival, optimal CD21/35 expression, and B-cell tolerance to dsDNA, since it is 95% identical to the wild-type (wt) BAFF-R and retains the only known signaling motif. A retrotransposon insertion in A/WySnJ strain mice generated the Bcmd-1 allele, replacing the eight C-terminal BAFF-R residues with 21 retrotransposon-encoded residues. New data reported here show that the displaced residues, previously thought to have no signaling role, are essential for optimal CD21/35 expression but contribute little to B cell survival signaling. Analysis of wt Baffr or Bcmd-1 homozygous (A/WySnJ X B6.BCL2)F2 mice confirmed that BCL2 complemented Bcmd-1 for B cell survival but not CD21/35 expression. Through in vivo retroviral transduction experiments, we show that Baffr complemented Bcmd-1 for B cell survival but not CD21/35 expression, whereas the BaffrDelta103-175 deletion mutant lacking the BAFF-R cytoplasmic domain failed to support these functions. Importantly, we show that the BaffrDelta168-175 deletion mutant lacking the retrotransposon-displaced residues, and a BaffrT170A mutant lacking a critical threonine, supported B cell survival but failed to support optimal CD21/35 expression. These data provide the first evidence for a possible bifurcation at the receptor level in the BAFF-R signaling pathway. We suggest that discrete BAFF-R cytoplasmic domains may interact with distinct downstream pathways to provide fine control over B cell survival, maturation, and tolerance induction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19815275      PMCID: PMC2787648          DOI: 10.1016/j.molimm.2009.09.010

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  36 in total

1.  Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice.

Authors:  D J Miller; C E Hayes
Journal:  Eur J Immunol       Date:  1991-05       Impact factor: 5.532

2.  BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2.

Authors:  Nobuhiko Kayagaki; Minhong Yan; Dhaya Seshasayee; Hua Wang; Wyne Lee; Dorothy M French; Iqbal S Grewal; Andrea G Cochran; Nathaniel C Gordon; JianPing Yin; Melissa A Starovasnik; Vishva M Dixit
Journal:  Immunity       Date:  2002-10       Impact factor: 31.745

3.  Enforced bcl-xL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice.

Authors:  Ian J Amanna; Jennifer P Dingwall; Colleen E Hayes
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

4.  Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation.

Authors:  Gongxian Liao; Minying Zhang; Edward W Harhaj; Shao-Cong Sun
Journal:  J Biol Chem       Date:  2004-04-14       Impact factor: 5.157

5.  TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology.

Authors:  Yoshiteru Sasaki; Stefano Casola; Jeffery L Kutok; Klaus Rajewsky; Marc Schmidt-Supprian
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

6.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.

Authors:  A Strasser; S Whittingham; D L Vaux; M L Bath; J M Adams; S Cory; A W Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

Review 7.  Protein kinase C family functions in B-cell activation.

Authors:  Beichu Guo; Thomas T Su; David J Rawlings
Journal:  Curr Opin Immunol       Date:  2004-06       Impact factor: 7.486

8.  The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF.

Authors:  Aubry Tardivel; Antoine Tinel; Susanne Lens; Quynh-Giao Steiner; Estelle Sauberli; Anne Wilson; Fabienne Mackay; Antonius G Rolink; Friedrich Beermann; Jürg Tschopp; Pascal Schneider
Journal:  Eur J Immunol       Date:  2004-02       Impact factor: 5.532

9.  Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function.

Authors:  Leonid Gorelik; Anne H Cutler; Greg Thill; Steven D Miklasz; Dianna E Shea; Christine Ambrose; Sarah A Bixler; Lihe Su; Martin L Scott; Susan L Kalled
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

10.  B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation.

Authors:  Svetlana Shulga-Morskaya; Max Dobles; Meghan E Walsh; Lai Guan Ng; Fabienne MacKay; Sambasiva P Rao; Susan L Kalled; Martin L Scott
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

View more
  4 in total

Review 1.  Targeting BAFF in autoimmunity.

Authors:  Anne Davidson
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

2.  BAFF receptor signaling aids the differentiation of immature B cells into transitional B cells following tonic BCR signaling.

Authors:  Sarah L Rowland; Katelyn F Leahy; Regina Halverson; Raul M Torres; Roberta Pelanda
Journal:  J Immunol       Date:  2010-09-22       Impact factor: 5.422

3.  Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.

Authors:  Mario L Santiago; Diana S Smith; Bradley S Barrett; Mauricio Montano; Robert L Benitez; Roberta Pelanda; Kim J Hasenkrug; Warner C Greene
Journal:  J Virol       Date:  2010-10-27       Impact factor: 5.103

4.  A Complex Relationship between TRAF3 and Non-Canonical NF-κB2 Activation in B Lymphocytes.

Authors:  Wai W Lin; Joanne M Hildebrand; Gail A Bishop
Journal:  Front Immunol       Date:  2013-12-20       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.